Robert Klitzman, MD, professor of psychiatry, addresses the ethical and health concerns that must be considered in tackling the obesity epidemic and broader public health challenges.
A Columbia study shows a simple smell test and memory exam can predict cognitive decline as accurately as costly brain imaging, offering a more affordable and accessible way to assess dementia.
Dr. Philip Muskin agrees no drug works for everyone, but he said a good doctor can usually find the ideal combination of medications to achieve the maximum benefit with the fewest side effects.
Dr. J. John Mann says while there are clear short-term benefits to ketamine, its long-term effects, its abuse potential and the optimal number of treatments a patient should receive are still unknown.
Dr. Kelly Posner Gerstenhaber says it's especially important for parents, teachers, coaches and friends to ask survivors direct questions about suicidal thoughts.
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
"This treatment brings in the parents, finally, and focuses on the ways parents need [to stop] taking over, to break the cycle of anxiety in kids," said Dr. Anne Marie Albano.
“There seems to be a general liability factor, which is genetically transmitted, to having a variety of different psychiatric and neurological disorders,” says Dr. Alan Brown.
Dr. Randy Auerbach spoke with BBC World Service about a clinical trial in which his team of researchers are monitoring adolescents at risk of suicide through their smartphones (forward to 43:26).